Clin2
NCT06726512Possibly a fitNot yet recruiting

Detailed imaging scan before surgery for oral or bone cancer

Oral CancerOsteosarcomaSoft Tissue SarcomaOral Squamous Cell Carcinoma (OSCC)

Part of Cancer, Mouth & dental clinical trials.

This study tests an advanced PET/CT scan that looks closely at the edges of your tumor before surgery to help the surgeon remove all the cancer. You will receive a special dye that helps the scan see the tumor better, and the scan results may help guide your surgery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years of age or older.
  • You must have one of these types of cancer: oral squamous cell carcinoma, soft tissue sarcoma, or osteosarcoma.
  • You must be scheduled to have surgery to remove your cancer.
  • You must not have had radiation therapy to the tumor area before.
  • You must not have had too much radiation exposure from research studies in the past year.
  • You must have a normal blood sugar level on the day of surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06321003Recruiting
Testing AI to detect early oral cancer with light scans

This trial uses a special light-based scanner (OCT) and artificial intelligence to help diagnose early signs of mouth cancer or precancer. It aims to see if this combination can make diagnosis easier and more accurate.

Palermo
NCT07028918Not yet recruiting· Early Phase 1
Low-dose radiation with immunotherapy and chemo for oral cancer

This trial is testing a combination of low-dose radiation, immunotherapy, and chemotherapy for people with advanced oral cancer that hasn't been treated before. The goal is to see if this approach can help control the cancer and possibly improve outcomes.

NCT07137858Not yet recruiting· Phase 2
Immunotherapy plus chemotherapy before surgery for advanced oral cancer

This trial tests a combination of an immunotherapy drug (adebrelimab) and two standard chemotherapy drugs (carboplatin and albumin-bound paclitaxel) before surgery for advanced oral cancer that can be removed. The goal is to see if this approach helps shrink the tumor and improve outcomes.

NCT06114225Recruiting· Phase 2
Immunotherapy and radiation before lung surgery for osteosarcoma

This trial tests a combination of immunotherapy and targeted radiation before surgery for osteosarcoma that has spread to the lungs. It aims to see if this approach can help shrink or control the lung tumors and make surgery more effective.

Shanghai, Shanghai Municipality
NCT06915454Recruiting
Better imaging during cancer surgery

This trial tests a high-resolution PET-CT scan done during surgery to help surgeons see exactly where the cancer ends. It may help make sure all cancer is removed while saving healthy tissue.

Nashville, Tennessee
NCT06970275Recruiting
PET-CT imaging study for cancer surgery patients

This trial uses a special PET-CT scanner to take high-resolution images of cancer tumors that have been surgically removed. The goal is to see how well these images match the results from standard lab tests, such as pathology, and to track long-term outcomes.

Aalst

Hear when a new Oral Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.